Review the next 20 articles from the approved list. Synthetize the information f

By
Responsive Centered Red Button

Need Help with this Question or something similar to this? We got you! Just fill out the order form (follow the link below), and your paper will be assigned to an expert to help you ASAP.

Order Form

Review the next 20 articles from the approved list. Synthetize the information for each article including the authors, the title, the type of research, the methodology used, the tool used, the results and the practice recommendation. Add the literature review to your Practice Change Project. Submit the literature review via Canvas for your mentor to provide feedback.
here Put again the 60 articles, you need take only the second 20 for now.
65– IV Prep Medication Workflow Solutions: SOLICITATION #: 36C25519Q0288. (2019). (). Washington: Federal Information & News Dispatch, LLC. https://go.exlibris.link/wRgkxzJ4
Adams, L. M., & Balderson, B. H. (2016). HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care, 28(9), 1154-1158. 10.1080/09540121.2016.1153595
Ahouada, C., Diabaté, S., Gning, N. N., Hessou, S., Batona, G., Guédou, F. A., Béhanzin, L., Zannou, M. D., & Alary, M. (2020). Acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Benin: a qualitative study. AIDS Care, 32(2), 242-248. 10.1080/09540121.2019.1622643
Amith, M. T., Cui, L., Roberts, K., & Tao, C. (2020). Towards an ontology-based medication conversational agent for PrEP and PEP. Proceedings of the Conference – Association for Computational Linguistics.Meeting, 2020, 31-40. 10.18653/v1/2020.nlpmc-1.5
Bass, S. B., Kelly, P. J., Brajuha, J., Gutierrez-Mock, L., Koester, K., D’Avanzo, P., & Sevelius, J. (2022). Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication. BMC Public Health, 22(1), 17. 10.1186/s12889-021-12425-w
Beima-Sofie, K. M., Trinidad, S. B., Ngure, K., Heffron, R., Baeten, J. M., John-Stewart, G. C., & Kelley, M. (2019). Lessons from PrEP: A Qualitative Study Investigating How Clinical and Policy Experts Weigh Ethics and Evidence When Evaluating Preventive Medications for Use in Pregnant and Breastfeeding Women. AIDS and Behavior, 23(7), 1858-1870. 10.1007/s10461-018-2361-5
Beymer, M. R., Holloway, I. W., Pulsipher, C., & Landovitz, R. J. (2019). Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.
Beymer, M. R., Holloway, I. W., Pulsipher, C., & Landovitz, R. J. (2019). Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals. Current HIV/AIDS Reports, 16(4), 349-358. 10.1007/s11904-019-00450-9
Biello, K. B., Mimiaga, M. J., Santostefano, C. M., Novak, D. S., & Mayer, K. H. (2018). MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication. AIDS and Behavior, 22(4), 1158-1164. 10.1007/s10461-017-1972-6
Burlen, J., Atassi, H., Tu, Y., Nguyen, V., Chaudhary, D., Ahmed, S., Liu, N., Furmanek, S., English, C., Krueger, K., Parajuli, D., & McClain, C. (2018). Association of Prescription Medications and Poor Bowel Prep Quality in Initial Screening Colonoscopies: 227. The American Journal of Gastroenterology, 113(Supplement), S132. 10.14309/00000434-201810001-00227
Chan, C., Fraser, D., Vaccher, S., Yeung, B., Jin, F., Amin, J., Dharan, N. J., Carr, A., Ooi, C., Vaughan, M., Holden, J., Power, C., Grulich, A. E., Bavinton, B. R., & MI-EPIC Research Group. (2021). Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trial. Sexual Health, 18(6), 453-459. 10.1071/SH21096
Chemtob, D., Weil, C., Hannink Attal, J., Hawila, E., & Noff Sadeh, E. (2021). HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis. PloS One, 16(11), e0259168. 10.1371/journal.pone.0259168
Coy, K. C., Hazen, R. J., Kirkham, H. S., Delpino, A., & Siegler, A. J. (2019). Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. Journal of the International AIDS Society, 22(2), e25252-n/a. 10.1002/jia2.25252
Doblecki-Lewis, S., Liu, A., Feaster, D., Cohen, S. E., Cardenas, G., Bacon, O., Andrew, E., & Kolber, M. A. (2017). Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project. Journal of Acquired Immune Deficiency Syndromes (1999), 74(5), 531-538. 10.1097/QAI.0000000000001236
Donnell, D., Baeten, J. M., Bumpus, N. N., Brantley, J., Bangsberg, D. R., Haberer, J. E., Mujugira, A., Mugo, N., Ndase, P., Hendrix, C., & Celum, C. (2014). HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. Journal of Acquired Immune Deficiency Syndromes (1999), 66(3), 340-348. 10.1097/QAI.0000000000000172
Egan, J. E., Ho, K., Stall, R., Drucker, M. T., Tappin, R., Hendrix, C. W., Marzinke, M. A., Safren, S. A., Mimiaga, M. J., Psaros, C., Elsesser, S., & Mayer, K. H. (2020). Feasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk. Journal of Acquired Immune Deficiency Syndromes (1999), 84(5), 508-513. 10.1097/QAI.0000000000002382
Fields, S. D., & Tung, E. (2021). Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review. Infectious Diseases and Therapy, 10(1), 165-186. 10.1007/s40121-020-00384-5
Findings on Marijuana/Cannabis Reported by Researchers at City University of New York Graduate School of Public Health and Health Policy (Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence …) (2019). . NewsRX LLC.
Grov, C., Flynn, A. W. P., D’Angelo, A. B., Lopez-Rios, J., Pantalone, D. W., Holloway, I. W., & Parsons, J. T. (2019). Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study. Prevention Science, 20(1), 168-177. 10.1007/s11121-019-0985-y
Grov, C., Rendina, H. J., John, S. A., & Parsons, J. T. (2019). Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research. AIDS and Behavior, 23(5), 1277-1286. 10.1007/s10461-018-2309-9
Hendrix, C. (2011). S1.4 Pharmacological assessment of medication adherence—oral PrEP and microbicides. Sexually Transmitted Infections, 87(Suppl 1), A1. 10.1136/sextrans-2011-050102.4
HHS Seeks Vendor(s) to Distribute PrEP Medications as Part of Ready, Set, PrEP (2019). . Newstex.
Hu, Y., Zhong, X., Peng, B., Zhang, Y., Liang, H., Dai, J., Zhang, J., & Huang, A. (2018). Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China. BMC Infectious Diseases, 18(1), 575. 10.1186/s12879-018-3497-7
Klein, H., & Washington, T. A. (2020a). Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV. Journal of AIDS and HIV Treatment, 2(2), 42.
Klein, H., & Washington, T. A. (2020b). Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV. Journal of AIDS and HIV Treatment, 2(2), 42-50. 10.33696/aids.2.006
Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-exposure Prophylaxis in Care Settings: A Qualitative Study. AIDS and Behavior, 18(9), 1712-1721. 10.1007/s10461-014-0839-3
Laborde, N. D., Kinley, P. M., Spinelli, M., Vittinghoff, E., Whitacre, R., Scott, H. M., & Buchbinder, S. P. (2020). Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS and Behavior, 24(9), 2509-2519. 10.1007/s10461-020-02807-3
Lal, L., Audsley, J., Murphy, D., Fairley, C. K., Stoove, M., Roth, N., Moore, R., Tee, B. K., Puratmaja, N., Anderson, P. L., Leslie, D., Grant, R. M., De Wit, J., Wright, E., & VicPrEP Study Team. (2017). Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project. AIDS (London),
Le, A. Q. (2017). Word-of-Mouth influence in prescription medication : Case: PrEP (Pre-Exposure Prophylaxis) – HIV prevention medication. Yrkeshögskolan Arcada.
Marcus, J. L., Buisker, T., Horvath, T., Amico, K. R., Fuchs, J. D., Buchbinder, S. P., Grant, R. M., & Liu, A. Y. (2014). Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions. HIV Medicine, 15(7), 385-395. 10.1111/hiv.12132
Matthews, L. T., Heffron, R., Mugo, N. R., Cohen, C. R., Hendrix, C. W., Celum, C., Bangsberg, D. R., Baeten, J. M., & Partners PrEP Study Team. (2014). High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999), 67(1), 91-97. 10.1097/QAI.0000000000000246
Maxwell, S., Shahmanesh, M., & Gafos, M. (2022). Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study. The International Journal of Drug Policy, 103, 103630. 10.1016/j.drugpo.2022.103630
Morgan, E., Moran, K., Ryan, D. T., Mustanski, B., & Newcomb, M. E. (2018). Threefold Increase in PrEP Uptake Over Time with High Adherence Among Young Men Who Have Sex With Men in Chicago. AIDS and Behavior, 22(11), 3637-3644. 10.1007/s10461-018-2122-5
Mujugira, A., Baeten, J. M., Hodges-Mameletzis, I., & Haberer, J. E. (2020). Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen. Drugs (New York, N.Y.), 80(18), 1881-1888. 10.1007/s40265-020-01419-4
New Findings from Pennsylvania State University (Penn State) Update Understanding of HIV/AIDS (Patient-focused Selection of Prep Medication for Individuals At Risk of Hiv: a Narrative Review) (2021). . NewsRX LLC.
Ngure, K. K., Trinidad, Susan Brown Susan Brown, Beima-Sofie, K. K., Kinuthia, J. J., Matemo, D. D., Kimemia, G. G., Njoroge, A. A., Achiro, L. L., Pintye, J. J., Mugo, Nelly R Nelly R., Bukusi, Elizabeth A Elizabeth A., Baeten, Jared M Jared M., Heffron, R. R., John-Stewart, G. G., & Kelley, Maureen C Maureen C. (2021). Perceived social influences on women’s decisions to use medications not studied in pregnancy: A qualitative ethical analysis of PrEP implementation research in Kenya. Journal of Empirical Research on Human Research Ethics, 16(3), 225-237. 10.1177/15562646211012296
Nieto, O., Brooks, R. A., Landrian, A., Cabral, A., & Fehrenbacher, A. E. (2020). PrEP discontinuation among Latino/a and Black MSM and transgender women: A need for PrEP support services. PloS One, 15(11), e0241340. 10.1371/journal.pone.0241340
O Murchu, E., Teljeur, C., Hayes, C., Harrington, P., Moran, P., & Ryan, M. (2021). Cost-Effectiveness Analysis of a National Pre-Exposure Prophylaxis (PrEP) Program in Ireland. Value in Health, 24(7), 948-956. 10.1016/j.jval.2021.02.005
Of, Adis Journals On Behalf, Fields, S. D., & Tung, E. (2020). Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review. Adis Journals. 10.6084/m9.figshare.13353098.v1
Of, Adis Journals On Behalf, Fields, S. D., & Tung, E. (2021). Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review. Adis Journals. 10.6084/m9.figshare.13353098.v2
Of, Adis Journals On Behalf, Fields, S. D., & Tung, E. (2021a). Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review. Adis Journals. 10.6084/m9.figshare.13353098
Of, Adis Journals On Behalf, Fields, S. D., & Tung, E. (2021b). Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review. Adis Journals. 10.6084/m9.figshare.13353098.v3
Roberts, S. T., Haberer, J., Celum, C., Mugo, N., Ware, N. C., Cohen, C. R., Tappero, J. W., Kiarie, J., Ronald, A., Mujugira, A., Tumwesigye, E., Were, E., Irungu, E., Baeten, J. M., Partners PrEP Study Team, & for the Partners PrEP Study Team. (2016). Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study. Journal of Acquired Immune Deficiency Syndromes (1999), 73(3), 313-322. 10.1097/QAI.0000000000001093
Romaine, J., Murray, M., & Bradley, C. (2019). PIH61 VALIDATION OF THE STUDY MEDICATION SATISFACTION QUESTIONNAIRE (SMSQ). A MEASURE OF MEDICATION SATISFACTION DESIGNED FOR INDIVIDUALS TAKING PRE-EXPOSURE PROPHYLAXIS (PREP) MEDICATION FOR HIV. Value in Health, 22, S638. 10.1016/j.jval.2019.09.1241
Rubin, R. (2020, ). HHS Provides Free PrEP Medication to People Without Drug Coverage. JAMA : The Journal of the American Medical Association10.1001/jama.2019.21077 https://go.exlibris.link/96BQc52W
Rubin, R. (2020). HHS Provides Free PrEP Medication to People Without Drug Coverage. JAMA : The Journal of the American Medical Association, 323(4), 300. 10.1001/jama.2019.21077
Sarfati, L., Ranchon, F., Vantard, N., Schwiertz, V., Gauthier, N., He, S., Kiouris, E., Gourc-Berthod, C., Guédat, M. G., Alloux, C., Gustin, M. -., You, B., Trillet-Lenoir, V., Freyer, G., & Rioufol, C. (2015). SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors. Journal of Clinical Pharmacy and Therapeutics, 40(1), 55-62. 10.1111/jcpt.12225
Schexnayder, J., Elamin, F., Mayes, E., Cox, L., Martin, E., & Webel, A. R. (2022). Is Tailoring of PrEP Programs Needed to Overcome Racial Disparities in PrEP Uptake in Local Health Departments? A Mixed-Methods Evaluation of PrEP Implementation in Virginia. Journal of Public Health Management and Practice, 28(3), 282-291. 10.1097/PHH.0000000000001463
Schoen, J. C. (2020). One-third of HIV PrEP users discontinued medication while sheltering in place. Infectious Disease News, 33(8), 34. https://go.exlibris.link/lj4W1n4r
Silapaswan, A., Krakower, D., & Mayer, K. H. (2017). Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. Journal of General Internal Medicine : JGIM, 32(2), 192-198. 10.1007/s11606-016-3899-4
Simmons measure passes Senate, would allow pharmacists to provide HIV testing, PrEP and PEP medications. (2022). Windy City Times,
Smith, D. K., Van Handel, M., & Huggins, R. (2017). Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015. Journal of Acquired Immune Deficiency Syndromes (1999), 76(5), 465-472. 10.1097/QAI.0000000000001532
Stekler, J. D., Scanlan, J. M., Simoni, J. M., Crane, H. M., Fredericksen, R. J., Marquard, J., & Saver, B. G. (2018). Predictors of Art and PrEP Adherence and Medication-Taking Practices and Preferences to Inform Development of a Wrist-Worn Adherence System. AIDS Education and Prevention, 30(5), 357-368. 10.1521/aeap.2018.30.5.357
Sullivan, P. S., Mena, L., Elopre, L., & Siegler, A. J. (2019). Implementation Strategies to Increase PrEP Uptake in the South. Current HIV/AIDS Reports, 16(4), 259-269. 10.1007/s11904-019-00447-4
Taylor, S. W., Psaros, C., Pantalone, D. W., Tinsley, J., Elsesser, S. A., Mayer, K. H., & Safren, S. A. (2017). “Life-Steps” for PrEP Adherence: Demonstration of a CBT-Based Intervention to Increase Adherence to Preexposure Prophylaxis (PrEP) Medication Among Sexual-Minority Men at High Risk for HIV Acquisition. Cognitive and Behavioral Practice, 24(1), 38-49. 10.1016/j.cbpra.2016.02.004
Thomson, K. A., Haberer, J. E., Marzinke, M. A., Mujugira, A., Hendrix, C. W., Celum, C., Ndase, P., Ronald, A., Bangsberg, D. R., Baeten, J. M., Partners PrEP Study Team, & for the Partners PrEP Study Team. (2017a). Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. Journal of Acquired Immune Deficiency Syndromes (1999), 75(2), 184-189. 10.1097/QAI.0000000000001356
Thomson, K. A., Haberer, J. E., Marzinke, M., Mujugira, A., Hendrix, C., Celum, C., Ndase, P., Ronald, A., Bangsberg, D. R., & Baeten, J. M. (2017b). Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention10.1097/QAI.0000000000001356
Velloza, J., Baeten, J. M., Haberer, J., Ngure, K., Irungu, E., Mugo, N. R., Celum, C., Heffron, R., Partners Demonstration Project Team, & for the Partners Demonstration Project Team. (2018). Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 79(3), 330-338. 10.1097/QAI.0000000000001821
Velloza, J., Kapogiannis, B., Bekker, L., Celum, C., Hosek, S., Delany-Moretlwe, S., Baggaley, R., & Dalal, S. (2020). Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services? AIDS (London), 10.1097/QAD.0000000000002777
Walmsley, B., Gallant, D., Naccarato, M., Hull, M., Smith, A., & Tan, D. H. (2019). The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications. Journal of Medical Internet Research, 21(7), e12076. 10.2196/12076

How to create Testimonial Carousel using Bootstrap5

Clients' Reviews about Our Services